Recent News

• 08.26.2025 - 8-K - Current report
• 08.22.2025 - DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 08.14.2025 - DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 08.14.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 07.22.2025 - DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 07.22.2025 - DEFM14A - Definitive proxy statement relating to merger or acquisition
• 06.27.2025 - 8-K - Current report
• 06.27.2025 - Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
• 06.18.2025 - 8-K - Current report
• 06.03.2025 - 425 - Prospectuses and communications, business combinations

Recent Filings

• 08.26.2025 - 8-K Current report
• 08.22.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 08.14.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 08.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.22.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 07.22.2025 - DEFM14A Definitive proxy statement relating to merger or acquisition
• 06.27.2025 - 8-K Current report
• 06.27.2025 - EX-99.1 EX-99.1
• 06.18.2025 - 8-K Current report